Lupin launches Mirabegron Extended-Release Tablets in the US EP News Bureau Sep 4, 2024 Mirabegron Extended-Release Tablets, 50 mg had estimated annual sales of $ 1,600 million in the US (IQVIA MAT July 2024)
Zydus launches Mirabegron ER tablets in US EP News Bureau Apr 22, 2024 Mirabegron is indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and…
US FDA approves Mirabegron extended-release tablets by Zydus EP News Bureau Oct 4, 2022 Mirabegron is indicated for the treatment of Over Active Bladder (OAB) with symptoms of urge urinary incontinence, urgency and…
